Category Archives: Cancer Research

CTCA – Best Field For Oncology.

Looking to make a positive impact on people’s lives while sharing a passion for helping people defeat cancer, a number of career options are available in the field of oncology.Cancer is the uncontrolled growth of abnormal cells in the body while oncology, which includes medical, radiation and surgical oncology, is the area of medicine that focuses on examining, evaluating and caring for cancer. New technologies have also made it possible to pursue more wide-ranging research goals.Specifically, the surgery option directly removes the tumor, radiation therapy uses X-rays to kill cancer cells and chemotherapy uses chemicals to kill cancer cells.The range of diverse medical professionals takes in anesthesiologists, case managers, oncology information specialists, radiation therapists, patient care technicians, and more.

Clinical data analysts, interns, naturopathic physicians, home health nurses, radiologists and licensed practical nurses are also among a number of the health care professionals a patient may become acquainted with during treatment. A surgical oncologist, for example, is a doctor who has special training in the diagnosis and treatment of cancer and uses surgery to treat cancer while a medical oncologist is a doctor who specializes in the diagnosis and treatment of cancer with chemotherapy and other drugs. An oncology clinical nurse specialist is a registered nurse with a Master’s Degree who focuses on the care of cancer patients.Salaries at the Cancer Treatment Centers of America for jobs span from roughly $69,000 for registered nurses to $235,000 for surgical oncologists, according to Glassdoor.com.

Naturopathic physician salaries are in the range of $88,000, oncology information specialists $55,000 and clinical data analysts in the $84,000 range.The Cancer Treatment Centers of America (CTCA), which was launched in 1988, makes the most of advanced technology and a personalized approach in the fight against cancer. It accomplishes this with the backing and support of its team of oncologists, surgeons and other health specialists.The CTCA examines the stage of the cancer, how much is present and how much has spread. Its robust, integrated oncology program involves blending together solutions such as chiropractic, nutritional, new targeted drug therapies and more for the individual patient.At CTCA employees are known as stakeholders since they have a share in victory over the fight against cancer each day.CTCA, which is headquartered in Boca Raton, Florida, is a national network of five hospitals with facilities in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa.

The Positive Impact of Clay Seagall to the Cancer Research World

Clay Siegall is a respected science professional who is recognized for the tremendous contributions that he has made towards the development of cancer treatments. He is highly skilled in biotechnology and genetics. Seigall was once hired by the various government and private research institutions to help in the development of gene-based cures. He has had a positive impact for the past three decades of his career. In 1998, Clay worked with different biotechnology professionals to start Seattle Genetics. The company’s primary focus is to deal with the development of cancer therapies that are safer for human treatment. Chemotherapies that are used by medical professional in curing the deadly disease are less efficient and have adverse side effects.

Over the years, Seattle Genetics has developed into a research hub that is served by several biotechnology experts. Some of the therapies that it has created have been licensed by the FDA. The firm was a pioneer in the formation of the antibody drug conjugates technology that is used in manufacturing cancer drugs. Seattle Genetics has generated millions of dollars from selling internally manufactured ADC drugs, offering licenses to pharmaceutical firms to use the technology, and joining effort with various multinational corporations to produce drugs externally. It has worked with companies such as Genentech, Bayer, and Takeda Pharmaceuticals. Seatle Genetics currently has more than 900 employees, and it is considered as the leading biotech firm in Washington. It enjoys a market that is worth about $10 billion.

Siegall has displayed excellent management skills for the past two decades that he has been the chairman of Seattle Genetics. He has led the researchers at the firm in establishing cancer cures that have saved the lives of many patients. Seattle Genetics is still focused on improving its cancer therapies by customizing them. Clay believes in the staff members of the company since they have assisted it in impacting the pharmaceuticals industry. The company’s shares rose from $20 to $66 in mid-May.

The biotechnology professional has acquired a lot of experience during his career life. This has enabled him to be appointed as a board member of leading companies such as Ultragenyx, BioPharmaceuticals, and Mirna Therapeutics. Clay has accomplished a lot during his research career at Seattle Genetics. He has discovered several new cures and holds 15 biotechnology patents. He has also published over 70 research-based articles. Siegall has a Ph.D. in genetics and a biotechnology degree.